Croda International PLC
30 April 2008
30 April 2008
Croda International Plc
AGM trading statement
Martin Flower, Chairman of Croda International Plc, is due to make the following
statement at today's Annual General Meeting:
'I am pleased to report that the exceptionally strong trading momentum seen in
the second half of 2007 was sustained throughout the first quarter as we
continued to experience robust demand for our products around the world.
For the 3 months ended 31 March 2008, continuing turnover increased to £265.3m,
up 16.4% from £227.9m in the same period last year. Continuing pre-tax profit
was up 84.8% to £27.9m compared to £15.1m in the first quarter of 2007. Our exit
from low margin commodity business reduced volumes but we made further progress
in sales, margins and profits in both our Consumer Care and Industrial
Specialities divisions.
During the quarter we increased our average selling prices by 16.5% over the
same period last year as we continue to fully recover input cost inflation. The
integration of Uniqema is going well and we remain on track to deliver synergies
of at least £30m per annum by the end of 2008.
Our robust underlying performance was further enhanced by the significant
increase in glycerine prices, which have more than doubled from the same period
last year, contributing an additional £4.5 million to Group profits. However, it
is likely that glycerine prices will weaken during the rest of the year. In
addition, the strong euro meant that we had favourable currency translation
overall during the first quarter.
Continuing our strategy to focus on core businesses, we sold our 46.5% interest
in Baxenden Chemicals for a total cash consideration of £13m on 29 February
2008. Assisted by our strong trading performance, this disposal helped to reduce
net debt from £366.0m at the year end to £356.8m by the end of the first
quarter.
This year we are moving to more detailed quarterly reporting in line with best
practice. A breakdown of the results for the first quarter, including sales
analysis, divisional sales and profit trends together with a quarterly split of
last year's results, is attached to this statement.
Overall, the outlook for 2008 remains favourable and the Board continues to be
confident of delivering further progress in line with its current expectations
for the full year.
Finally, Croda will be announcing its interim results on 29 July 2008.'
For further information, please contact:
Mike Humphrey, Group Chief Executive Tel: 01405 860551
Sean Christie, Group Finance Director
Charlie Armitstead, Financial Dynamics Tel: 020 7269 7275
The company will host a conference call for analysts at 8.00am today:
Dial-In: +44 (0) 1452 542 303
Please quote 44 66 80 70 to gain access to the call
Croda International Plc
Unaudited income statement before exceptional items
31 March 2008
£m
3 months to 3 months to
31 March 31 March
2008 2007 Change
Consumer Care 112.5 99.8
Industrial Specialities 152.8 128.1
Revenues from continuing operations 265.3 227.9 16.4%
Consumer Care 23.7 18.5
Industrial Specialities 8.4 2.3
Operating profit from continuing operations 32.1 20.8 54.3%
Continuing operations operating margin 12.1% 9.1%
Net bank and loan interest payable (5.8) (6.9)
Net retirement benefit scheme interest receivable 1.6 1.2
Profit before tax from continuing operations 27.9 15.1 84.8%
Profit after tax from discontinued operations 0.3 1.6
Analysis of turnover uplift
Continuing operations sales volumes -5.6%
Currency impact 5.5%
Price/mix 16.5%
16.4%
2007 trading by Quarter
Q1 Q2 Q3 Q4 Year
Consumer Care 99.8 93.4 95.6 86.2 375.0
Industrial Specialities 128.1 119.8 122.7 140.5 511.1
Revenues from continuing operations 227.9 213.2 218.3 226.7 886.1
Consumer Care 18.5 18.5 18.3 19.6 74.9
Industrial Specialities 2.3 2.3 2.3 5.8 12.7
Operating profit from continuing operations 20.8 20.8 20.6 25.4 87.6
Interest (5.7) (5.8) (5.9) (4.8) (22.2)
Profit before tax from continuing operations 15.1 15.0 14.7 20.6 65.4
Profit after tax from discontinued operations 1.6 2.2 2.0 1.2 7.0
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.